Oriana Esposito
About Oriana Esposito
Oriana Esposito is the Senior Director, Clinical Scientist, Hematology Therapeutic Area Lead, Early Clinical Development at Bristol Myers Squibb in Switzerland.
Current Role at Bristol Myers Squibb
Oriana Esposito currently holds the position of Senior Director, Clinical Scientist, Hematology Therapeutic Area Lead, Early Clinical Development at Bristol Myers Squibb in Switzerland. In her role, Oriana is responsible for leading clinical development efforts in the hematology therapeutic area. Her responsibilities include overseeing clinical data review, interpretation of final results, and acting as the primary point of contact for investigators and key opinion leaders.
Previous Experience at Celgene
Prior to her current role, Oriana Esposito served as Director, Clinical Scientist, Early Clinical Development Hematology Oncology and Cell Therapy at Celgene from 2015 to 2022. During her seven-year tenure in Switzerland, she was involved in authoring clinical trial protocols, contributing to regulatory documents, and coordinating global study team activities. Her role also included supporting key operational aspects of clinical trials, such as Contract Research Organization (CRO) management.
Education and Certifications
Oriana Esposito has an extensive educational background. She holds a PhD in Medicinal and Pharmaceutical Chemistry from the University of Sussex (2004-2008). She earned her MSc in Medical Toxicology from Cardiff University and completed specialized training programs in oncology at St. James’s University Hospital and clinical research at GIMBE. Additional credentials include a degree in Industrial Chemistry from Università degli Studi di Napoli Federico II and certifications in Medicinal Chemistry and chemical synthesis from Leiden University and Università degli Studi di Siena.
Professional Experience in Clinical Trials
Throughout her career, Oriana Esposito has actively contributed to the field of clinical trials across multiple therapeutic areas, including respiratory, oncology, and hematology. She has authored clinical trial protocols, participated in medical monitoring, and provided scientific support for patent drafting. Oriana also has experience leading global study team activities, organizing committee meetings, and ensuring adherence to regulatory and scientific standards.
Drug Discovery and Development Expertise
Oriana Esposito has a robust background in drug discovery, design, and synthesis. Her work has involved optimizing pharmacological profiles of potential drug candidates based on medicinal chemistry rationales and Structure-Activity Relationships (SARs). She has analyzed pharmacological data and scientific literature to produce internal reports, presentations, and publications. Additionally, Oriana has been involved in inventing patents for new potential drugs and providing scientific support for patent drafting.